SMS Lifesciences India Ltd Q3FY23 consolidated profit higher at Rs. 3.98 crore

SMS Lifesciences India Limited has reported Consolidated financial results for the period ended December 31, 2022.

Financial Results (Q3 FY2023) - QoQ Comparison

The company has reported total income of Rs. 88.7963 crores during the period ended December 31, 2022 as compared to Rs. 81.4090 crores during the period ended September 30, 2022.

The company has posted net profit / (loss) of Rs. 3.9859 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 2.7518 crores for the period ended September 30, 2022.

The company has reported EPS of Rs. 13.18 for the period ended December 31, 2022 as compared to Rs. 9.10 for the period ended September 30, 2022.

Financials	Q3 FY2023	Q2 FY2023	% Change
Total Income	₹88.7963 crs	₹81.4090 crs	9.07%
Net Profit	₹3.9859 crs	₹2.7518 crs	44.85%
EPS	₹13.18	₹9.10	44.84%

Financial Results (Q3 FY2023) - YoY Comparison

The company has reported total income of Rs.88.7963 crores during the period ended December 31, 2022 as compared to Rs.91.0939 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.3.9859 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.2.3291 crores for the period ended December 31, 2021.

The company has reported EPS of Rs.13.18 for the period ended December 31, 2022 as compared to Rs.7.70 for the period ended December 31, 2021.

Financials	Q3 FY2023	Q3 FY2022	% Change
Total Income	₹88.7963 crs	₹91.0939 crs	-2.52%
Net Profit	₹3.9859 crs	₹2.3291 crs	71.13%
EPS	₹13.18	₹7.70	71.17%

Financial Results (9 Months Ended FY2023) - YoY Comparison

The company has reported total income of Rs.252.3351 crores during the 9 Months period ended December 31, 2022 as compared to Rs.254.4324 crores during the 9 Months period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.9.7463 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.16.2092 crores for the 9 Months period ended December 31, 2021.

The company has reported EPS of Rs.32.24 for the 9 Months period ended December 31, 2022 as compared to Rs.53.61 for the 9 Months period ended December 31, 2021.

Financials	9 Months Ended FY2023	9 Months Ended FY2022	% Change
Total Income	₹252.3351 crs	₹254.4324 crs	-0.82%
Net Profit	₹9.7463 crs	₹16.2092 crs	-39.87%
EPS	₹32.24	₹53.61	-39.86%

Shares of SMS Lifesciences India Limited was last trading in BSE at Rs. 556.95 as compared to the previous close of Rs. 582.05. The total number of shares traded during the day was 474 in over 61 trades.

The stock hit an intraday high of Rs. 574.50 and intraday low of 552.00. The net turnover during the day was Rs. 265406.00.

Source : Equity Bulls

Keywords

SMSLifesciencesIndia Q3FY23 9MFY23 ResultUpdate